Numeric Investors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-517,518
| Closed | -$5.8M | – | 1281 |
|
|
2017
Q3 | $5.8M | Sell |
517,518
-15,629
| -3% | -$172K | 0.04% | 375 |
|
|
2017
Q2 | $5.87M | Buy |
533,147
+154,840
| +41% | +$1.55M | 0.05% | 306 |
|
|
2017
Q1 | $3.71M | Sell |
378,307
-554,390
| -59% | -$5.54M | 0.03% | 384 |
|
|
2016
Q4 | $10.1M | Sell |
932,697
-1,624,926
| -64% | -$16.2M | 0.09% | 231 |
|
|
2016
Q3 | $26.2M | Buy |
2,557,623
+2,082,147
| +438% | +$22.7M | 0.25% | 93 |
|
|
2016
Q2 | $6.21M | Sell |
475,476
-464,265
| -49% | -$6.08M | 0.06% | 279 |
|
|
2016
Q1 | $10.3M | Sell |
939,741
-150,016
| -14% | -$1.33M | 0.11% | 193 |
|
|
2015
Q4 | $10M | Buy |
1,089,757
+377,777
| +53% | +$3.16M | 0.11% | 199 |
|
|
2015
Q3 | $4.94M | Sell |
711,980
-473,534
| -40% | -$4.06M | 0.06% | 242 |
|
|
2015
Q2 | $11.6M | Buy |
1,185,514
+182,700
| +18% | +$1.66M | 0.13% | 151 |
|
|
2015
Q1 | $8.88M | Buy |
1,002,814
+140,000
| +16% | +$1.12M | 0.11% | 190 |
|
|
2014
Q4 | $7.56M | Buy |
862,814
+677,314
| +365% | +$5.48M | 0.1% | 183 |
|
|
2014
Q3 | $1.28M | Buy |
+185,500
| New | +$1.11M | 0.02% | 391 |
|
Numeric Investors's SCLN Position: Q4 2017 in Review
Numeric Investors sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 517,518 shares — an estimated $5.8M sold.
Numeric Investors first reported a position in SCLN in Q3 2014 and held it in 13 quarters. The position peaked at $26.2M in Q3 2016. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.
- Numeric Investors reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
- Numeric Investors sold 517,518 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $5.8M.
- Numeric Investors first reported a position in Sciclone Pharmaceuticals Inc in Q3 2014 and held it in 13 quarters.
- Numeric Investors's Sciclone Pharmaceuticals Inc position peaked at $26.2M in Q3 2016.
- 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.
Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.